HOTH News and Press, Hoth Therapeutics Inc. From 09/18/19

CEO Interviews with: HEXO, HOTH, MDCL, NEXCF News & VIDEO from Investor Conferences: NEXCF, MDCL NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, and conference presen...

NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, video presentations, and news updates from the company’s presenting at last month’s NEXT SUPER STOCK Live! inves...

NEW YORK, NY / ACCESSWIRE / September 16, 2019 / Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies has initiated coverage of Hoth Therapeutics, Inc. (NASDAQ: HOTH ). The in-depth 24-page initiation report includ...

NEW YORK , Sept. 6, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chron...

NEW YORK , Sept. 4, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis to chronic wound disorders, today issued a letter to s...

Hoth Therapeutics (NASDAQ: HOTH ) inks an agreement with Greenville, SC-based Zylö Therapeutics to develop an new topical therapy for cutaneous lupus erythematosus  (CLE), an autoimmune disorder affecting the skin. More news on: Hoth Therapeutics, Inc., Healthcare stocks new...

NEW YORK , Aug. 21, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis to chronic wound disorders, today announced it...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) was in the red again last week, falling from 3,283.64 points on Monday’s (July 22) open to 3,283.82 points as of 1:58 p.m. EDT on Friday (July 26). On Thursday (July 25),  news hit that the US Food and Drug Administration (FDA) ...

Gainers : Therapix Biosciences (NASDAQ: TRPX ) +45% . Chiasma (NASDAQ: CHMA ) +31% . Achillion Pharmaceuticals (NASDAQ: ACHN ) +24% . Hoth Therapeutics (NASDAQ: HOTH ) +20% . Torchlight Energy Resources (NASDAQ: TRCH ) +17% . Realogy Holdings (NYSE: RLGY ) +16% . ClearSign Combustion...

Ultra-thinly traded nano cap Hoth Therapeutics ( HOTH ) is up  9% , albeit on only 369 shares, on the heels of positive results from a pilot study of BioLexa for patients with diabetic skin ulcers. More news on: Hoth Therapeutics, Inc., Healthcare stocks news, Stocks on the move, ...